ALEMBIC LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.4 INR | +0.47% |
|
+6.51% | +28.35% |
| May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
| May. 13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Real Estate Development & Operations
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 357M | - | - | - | - | - | |
| 25.71B | ||||||
| 24.63B | ||||||
| 24.96B | ||||||
| 23.51B | ||||||
| 19.59B |
